Yan Li

Yan Li is the Clinical Bioanalysis Alliance Program Director at AstraZeneca, bringing over 20 years of experience in Drug Metabolism and Pharmacokinetics (DMPK) across both discovery and development phases. Yan has a proven track record in delivering high-quality bioanalysis data for regulatory submissions and has extensive knowledge of clinical trial setup and regulatory guidelines. Previously, Yan served as a Senior Scientist at DuPont and held various roles at AstraZeneca, including DMPK Project Leader and Principal Scientist II. Yan earned a Ph.D. in Organic Chemistry from Rice University.